Log in to your Inderes Free account to see all free content on this page.
Spermosens
0.01 SEK
+4.44 %
Less than 1K followers
SPERM
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+4.44 %
+56.67 %
+62.07 %
+46.88 %
+34.29 %
+17.50 %
-96.56 %
-
-99.03 %
Spermosens operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes products for male infertility and individually tailored fertility treatments. Research and development is conducted via its own technological platform that analyzes sperm quality, which is further used for medical support and potential fertilization. The largest operations are found in the Nordic market.
Read moreMarket cap
29.83M SEK
Turnover
46.83K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5.
2026
Interim report Q1'26
18.6.
2026
General meeting '26
20.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Spermosens AB (publ)YEAR-END REPORT JANUARY - DECEMBER 2025
Spermosens and RSI sign Memorandum of Understanding to advance male fertility diagnostics in the US
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio